Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICH To Partner For Training Of Regulators, Industry On Key Guidelines

Executive Summary

The organization that works to harmonize drug review requirements across a growing number of regulatory authorities aims to partner with non-profit groups to train regulatory authorities and industry on its guidelines, starting with guidelines on stability testing, good clinical practice and good manufacturing practices for active pharmaceutical ingredients.

You may also be interested in...



ICH Hires Trainers As Emerging Authorities Strive To Harmonize

ICH prepares to lift veil on global regulatory harmonization progress as it hires trainers to speed up the process.

Regulatory Updates in Brief

ICH association convenes; ISO revises cleanroom standards; NSF accredited for excipient GMP certification; supply chain library launched.

ICH Reforming in Ways that Could Strengthen Harmonization Process

Twenty-five years after its founding, the organization where the world’s foremost regulatory authorities and industry groups reach agreement on pharmaceutical quality guidelines will incorporate next year in Switzerland. The new Swiss association could strengthen the role of emerging-market authorities in global regulatory harmonization – at least those that meet its membership criteria.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS125139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel